Genome-scale identification method applied to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Struble, Julie M ^a   Gill, Ryan T ^a  

^a UCB 450   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; TOBRAMYCIN; AMINOGLYCOSIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; GENE IDENTIFICATION; GENE LIBRARY; GENOMICS; MICROARRAY ANALYSIS; NONHUMAN; OPEN READING FRAME; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; BACTERIAL GENOME; BIOLOGY; CLUSTER ANALYSIS; DNA MICROARRAY; DRUG EFFECT; GENETICS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; PHENOTYPE;

PSEUDOMONAS AERUGINOSA;

AMIKACIN; AMINOGLYCOSIDES; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DRUG RESISTANCE, BACTERIAL; GENOME, BACTERIAL; GENOMICS; GENTAMICINS; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPEN READING FRAMES; PHENOTYPE; PSEUDOMONAS AERUGINOSA; TOBRAMYCIN;

EID: 70450181378     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006576     Document Type: Article

References (61)

1. Lynch MD, Warnecke T, Gill RT (2007) SCALEs: multiscale analysis of library enrichment. Nat Methods 4: 87-93.
2. Leeb M (2004) Antibiotics: a shot in the arm. Nature 431: 892-893.
3. Wenzel RP (2004) The antibiotic pipeline-challenges, costs, and values. N Engl J Med 351: 523-526.
4. Courvalin P (1999) Combinatorial approach of bacteria to antibiotic resistance. Res Microbiology 150: 1-7.
5. Baquero F (2001) Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resistance Updates 4: 93-105.
6. Aminoglycoside Resistance Study Groups (1995) The most frequently occurring aminoglycoside resistance mechanisms-combined results of surveys in eight regions of the world. J Chemother 7 Suppl 2: 17-30.
7. Shaw K, Rather P, Hare R, Miller G (1993) Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside modifying enzymes. Microbiology Reviews 57: 138-163.
8. Martinez J, Baquero F (2000) Mutation Frequencies and Antibiotic Resistance. Antimicrobial Agents and Chemotherapy 44: 1771-1777.
9. Komp Lindgren P, Marcusson LL, Sandvang D, Frimodt-Moller N, Hughes D (2005) Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother 49: 2343-2351.
10. Normark BH, Normark S (2002) Evolution and spread of antibiotic resistance. J Intern Med 252: 91-106.
11. Hall B (2004) Predicting the evolution of antibiotic resistance genes. Nature Microbiology Reviews 2: 430-435.
12. Lawhorn BG, Gerdes SY, Begley TP (2004) A genetic screen for the identification of thiamin metabolic genes. J Biol Chem 279: 43555-43559.
13. Salipante SJ, Barlow M, Hall BG (2003) GeneHunter, a transposon tool for identification and isolation of cryptic antibiotic resistance genes. Antimicrob Agents Chemother 47: 3840-3845.
14. Levin B, Perrot V, Walker N (2000) Compensatory Mutations, Antibiotic Resistance, and the Population Genetics of Adaptive Evolution in Bacteria. Genetics 154: 985-997.
15. Bjorkman J, Nagaev I, Berg O, Hughes D, Andersson D (2000) Effects of Environments on Compensatory Mutations to Ameliorate Costs of Antibiotic Resistance. Science 287: 1479-1482.
16. Kepler T, Perelson A (1998) Drug concentration heterogeneity facilitates the evolution of drug resistance. Proceedings of the National Academy of Sciences 95: 11514-11519.
17. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103: 8487-8492.
18. Kenna DT, Doherty CJ, Foweraker J, Macaskill L, Barcus VA, et al. (2007) Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis. Microbiology 153: 1852-1859.
19. Frangipani E, Slaveykova VI, Reimmann C, Haas D (2008) Adaptation of aerobically growing Pseudomonas aeruginosa to copper starvation. J Bacteriol 190: 6706-6717.
20. Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, et al. (2008) Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad Sci U S A 105: 3100-3105.
21. Schroeder R, Waldsich C, Wank H (2000) Modulation of RNA function by aminoglycoside antibiotics. Embo Journal 19: 1-9.
22. Mingeot-Leclercq M, Glupczynski Y, Tulkens P (1999) Aminoglycosides: Activity and Resistance. Antimicrobial Agents and Chemotherapy 43.
23. Fourmy D, Recht MI, Blanchard SC, Puglisi JD (1996) Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274: 1367-1371.
24. Davis BD, Chen LL, Tai PC (1986) Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc Natl Acad Sci U S A 83: 6164-6168.
25. Poole K (2005) Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49: 479-487.
26. Yokoyama K, Doi Y, Yamane K, Kurokawa H, Shibata N, et al. (2003) Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 362: 1888-1893.
27. Lynch M, Conery JS (2000) The evolutionary fate and consequences of duplicate genes. Science 290: 1151-1155.
28. Lynch MD, Gill RT (2006) Broad host range vectors for stable genomic library construction. Biotechnol Bioeng 94: 151-158.
29. Benveniste R, Davies J (1973) Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups. Antimicrob Agents Chemother 4: 402-409.
30. Struble JM, Gill RT (2006) Reverse engineering antibiotic sensitivity in a multidrug-resistant Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother 50: 2506-2515.
31. Tatusov RL, Koonin EV, Lipman DJ (1997) A genomic perspective on protein families. Science 278: 631-637.
32. Finn RD, Mistry J, Schuster-Bockler B, Griffiths-Jones S, Hollich V, et al. (2006) Pfam: clans, web tools and services. Nucleic Acids Res 34: D247-251.
33. Nugent ME, Bone DH, Datta N (1979) A transposon, Tn732, encoding gentamicin/tobramycin resistance. Nature 282: 422-423.
34. Lee JK, Lee YS, Park YK, Kim BS (2005) Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 25: 290-295.
35. Hopkins KL, Davies RH, Threlfall EJ (2005) Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25: 358-373.
36. Sun HK, Du X, DeRyke CA, Doern GV, Nicolau DP (2007) parE mutations in Streptococcus pneumoniae may reduce bactericidal activity of respiratory fluoroquinolones. Int J Antimicrob Agents 29: 230-232.
37. Oyamada Y, Ito H, Inoue M, Yamagishi J (2006) Topoisomerase mutations and efflux are associated with fluoroquinolone resistance in Enterococcus faecalis. J Med Microbiol 55: 1395-1401.
38. Jacoby GA (2005) Mechanisms of resistance to quinolones. Clin Infect Dis 41 Suppl 2: S120-126.
39. Bakker EP (1992) Aminoglycoside and aminocyclitol antibiotics: hygromycin B is an atypical bactericidal compound that exerts effects on cells of Escherichia coli characteristics for bacteriostatic aminocyclitols. J Gen Microbiol 138: 563-569.
40. Matsunaga K, Yamaki H, Nishimura T, Tanaka N (1986) Inhibition of DNA replication initiation by aminoglycoside antibiotics. Antimicrob Agents Chemother 30: 468-474.
41. Valentin-Hansen P, Eriksen M, Udesen C (2004) The bacterial Sm-like protein Hfq: a key player in RNA transactions. Mol Microbiol 51: 1525-1533.
42. Gottesman S, McCullen CA, Guillier M, Vanderpool CK, Majdalani N, et al. (2006) Small RNA regulators and the bacterial response to stress. Cold Spring Harb Symp Quant Biol 71: 1-11.
43. Horn G, Hofweber R, Kremer W, Kalbitzer HR (2007) Structure and function of bacterial cold shock proteins. Cell Mol Life Sci 64: 1457-1470.
44. Geissmann TA, Touati D (2004) Hfq, a new chaperoning role: binding to messenger RNA determines access for small RNA regulator. Embo J 23: 396-405.
45. Brown L, Elliott T (1996) Efficient translation of the RpoS sigma factor in Salmonella typhimurium requires host factor I, an RNA-binding protein encoded by the hfq gene. J Bacteriol 178: 3763-3770.
46. Muffler A, Traulsen DD, Fischer D, Lange R, Hengge-Aronis R (1997) The RNA-binding protein HF-I plays a global regulatory role which is largely, but not exclusively, due to its role in expression of the sigmaS subunit of RNA polymerase in Escherichia coli. J Bacteriol 179: 297-300.
47. Vytvytska O, Moll I, Kaberdin VR, von Gabain A, Blasi U (2000) Hfq (HF1) stimulates ompA mRNA decay by interfering with ribosome binding. Genes Dev 14: 1109-1118.
48. Fourmy D, Recht MI, Puglisi JD (1998) Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA. J Mol Biol 277: 347-362.
49. Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, et al. (2000) Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407: 340-348.
50. Morita Y, Sobel ML, Poole K (2006) Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene product. J Bacteriol 188: 1847-1855.
51. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797-810.
52. Holloway BW (1969) Genetics of Pseudomonas. Bacteriol Rev 33: 419-443.
53. Chandler PM, Krishnapillai V (1974) Isolation and properties of recombination-deficient mutants of Pseudomonas aeruginosa. Mutat Res 23: 15-23.
54. Neidhardt FC, Bloch PL, Smith DF (1974) Culture medium for enterobacteria. J Bacteriol 119: 736-747.
55. Mdluli KE, Witte PR, Kline T, Barb AW, Erwin AL, et al. (2006) Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa. Antimicrob Agents Chemother 50: 2178-2184.
56. Sezonov G, Joseleau-Petit D, D'Ari R (2007) Escherichia coli physiology in Luria-Bertani broth. J Bacteriol 189: 8746-8749.
57. Zimelis VM, Jackson GG (1973) Activity of aminoglycoside antibiotics against Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism. J Infect Dis 127: 663-669.
58. Zhu H, Dean RA (1999) A novel method for increasing the transformation efficiency of Escherichia coli-application for bacterial artificial chromosome library construction. Nucleic Acids Res 27: 910-911.
59. Choi KH, Kumar A, Schweizer HP (2006) A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation. J Microbiol Methods 64: 391-397.
60. Winsor GL, Lo R, Sui SJ, Ung KS, Huang S, et al. (2005) Pseudomonas aeruginosa Genome Database and PseudoCAP: facilitating community-based, continually updated, genome annotation. Nucleic Acids Res 33: D338-343.
61. Kerkhoven R, van Enckevort FH, Boekhorst J, Molenaar D, Siezen RJ (2004) Visualization for genomics: the Microbial Genome Viewer. Bioinformatics 20: 1812-1814.